2-(ω-Carboxyethyl)pyrrole Antibody as a New Inhibitor of Tumor Angiogenesis and Growth.

about

2-(ω-Carboxyethyl)pyrrole Antibody as a New Inhibitor of Tumor Angiogenesis and Growth.

Item

http://www.wikidata.org/entity/Q38743607

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

2-(ω-Carboxyethyl)pyrrole Antibody as a New Inhibitor of Tumor Angiogenesis and Growth.

@en

type

Item

label

2-(ω-Carboxyethyl)pyrrole Antibody as a New Inhibitor of Tumor Angiogenesis and Growth.

@en

prefLabel

2-(ω-Carboxyethyl)pyrrole Antibody as a New Inhibitor of Tumor Angiogenesis and Growth.

@en

P1476

2-(ω-Carboxyethyl)pyrrole ...... Tumor Angiogenesis and Growth

@en

P2093

Bin Wangf

http://www.w3.org/2001/XMLSchema#string

Chunying Wu

http://www.w3.org/2001/XMLSchema#string

Jinle Zhu

http://www.w3.org/2001/XMLSchema#string

Junqing Zhu

http://www.w3.org/2001/XMLSchema#string

Nicholas Tomko

http://www.w3.org/2001/XMLSchema#string

William R Wang

http://www.w3.org/2001/XMLSchema#string

Xizhen Wang

http://www.w3.org/2001/XMLSchema#string

Yanming Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Tumor angiogenesis: therapeutic implications

CEP biomarkers as potential tools for monitoring therapeutics

Blood vessels as targets in tumor therapy

Molecular mechanisms and clinical applications of angiogenesis

Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors

Angiogenesis as a therapeutic target

A randomized trial of bevacizumab for newly diagnosed glioblastoma

AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients.

Phase II trial of infusional fluorouracil, irinotecan, and bevacizumab for metastatic colorectal cancer: efficacy and circulating angiogenic biomarkers associated with therapeutic resistance

18F-fluromisonidazole PET imaging as a biomarker for the response to 5,6-dimethylxanthenone-4-acetic acid in colorectal xenograft tumors.

P304

813-820

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2174/1871520616666160923093959

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Robert G. Salomon

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27671308

http://www.w3.org/2001/XMLSchema#string

P932

6002755

http://www.w3.org/2001/XMLSchema#string